MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SNSE has $205,381K in assets. $14,191K in debts. $152,325K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1439.27%
Quick Ratio
1439.27%
Cash Ratio
1073.47%
Debt to Asset Ratio
6.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Series b redeemable convertible ...
    • Additional paid-in capital
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
152,325 8,668 10,562 12,557
Marketable securities
50,468 12,516 14,479 16,071
Prepaid expenses
974 231 496 828
Other current assets
465 92 248 116
Total current assets
204,232 21,507 25,785 29,572
Right of use assets - operating leases, net
913 1,294 1,668 2,034
Right of use assets - financing leases, net
0 1 6 10
Total property and equipment
650 622 622 -
Less accumulated depreciation and amortization
581 540 510 -
Property and equipment, net
69 82 112 143
Other non-current assets
167 18 18 24
Total assets
205,381 22,902 27,589 31,783
Accounts payable and accrued expenses
8,982 1,481 1,405 1,135
Compensation and employee benefits liabilities
4,169 1,320 1,156 775
Operating lease liabilities, current
1,021 1,370 1,682 1,622
Financing lease liabilities, current
18 80 193 341
Total current liabilities
14,190 4,251 4,436 3,873
Operating lease liabilities, non-current
0 59 146 592
Financing lease liabilities, non-current
-0 0 4
Other non-current liabilities
1 ---
Total liabilities
14,191 4,310 4,582 4,469
Series b redeemable convertible preferred stock, 0.0001 par value 25,045 and 0 shares authorized as of march 31, 2026 and december 31, 2025, respectively 24,937 and 0 shares issued and outstanding as of march 31, 2026, and december 31, 2025, respectively liquidation value of 0 as of march 31, 2026
328,476 ---
Additional paid-in capital
316,111 301,728 301,431 301,177
Accumulated deficit
-453,373 -283,137 -278,421 -273,852
Accumulated other comprehensive (loss) income
-24 1 -3 -11
Total stockholders' (deficit) equity
-137,286 18,592 23,007 27,314
Total liabilities, redeemable convertible preferred stock, and stockholders' (deficit) equity
205,381 22,902 27,589 31,783
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$152,325K Marketable securities$50,468K Prepaid expenses$974K Other current assets$465K Total property andequipment$650K Total current assets$204,232K Right of use assets -operating leases, net$913K Other non-currentassets$167K Property and equipment,net$69K Less accumulateddepreciation and...$581K Total assets$205,381K Accumulated deficit-$453,373K Accumulated othercomprehensive (loss) income-$24K Total liabilities,redeemable convertible...$205,381K Total stockholders'(deficit) equity-$137,286K Additional paid-in capital$316,111K Series b redeemableconvertible preferred...$328,476K Total liabilities$14,191K Total currentliabilities$14,190K Other non-currentliabilities$1K Accounts payable andaccrued expenses$8,982K Compensation and employeebenefits liabilities$4,169K Operating leaseliabilities, current$1,021K Financing leaseliabilities, current$18K

Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics, Inc. (SNSE)